Safety and antiviral activity of combination therapy with zidovudine, zalcitabine, and two doses of interferon-alpha2a in patients with HIV. AIDS Clinical Trials Group Study 197.
暂无分享，去创建一个
D. Richman | M. Saag | K. Squires | J. Holden-Wiltse | M. Fischl | T. Meng | P. Meehan | M. A. Fischl | Richman Dd | Kathleen E. Squires | Michael S Saag | Tze Chiang Meng | Jeanne Holden-Wiltse